Biosimilars are biological products that are similar to FDA-approved drug known as branded drug. Biosimilars are drugs licensed by the European Medicines Agency (EMA) and the U.S. FDA. These do not have significant differences from the reference products in terms of purity, effectiveness, and safety. Biosimilar drugs can only be permitted for conditions and indications that have been formerly accepted for the reference product by government regulatory agencies and organizations, when the ... Read more